EUS-directed Transenteric ERCP (EDEE) in Patients With Benign and Malignant Underlying Conditions and Inaccessible Papilla/Biliodigestive Anastomosis (BDA)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEvangelisches Krankenhaus Düsseldorf

About this trial

Safety and efficacy of EDEE (EUS-directed transenteric ERCP)

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

signed consent form

Indication for an EDEE

Age >18 years

Disqualifiers

Age < 18 years

Trial design

Design model

Single group

Treatments tested in this trial

  • EDEE (EUS-directed transenteric ERCP)

    Procedure/Surgery

    Technical aspects of EUS-guided anastomosis and ERCP via LAMS (Lumen apposing metal stent)

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: EDEEExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Technical success rate

number an rate of patients with successful creation of gastro-enterostomy followed by successfull ERCP via LAMS (lumen apposing metal stent) including all planned interventions

Time frame
during the procedure
2

Safety of EDEE

number and rate of patients, in whom a procedure related complication occured

Time frame
during the procedure

Secondary outcomes

1

Clinical success rate

absence of need for alternative drainage

Time frame
at the day of last procedure
2

Technical aspects of gastro-enterostomy

Evaluation of devices and potential pitfalls creating a gastroenterostomy

Time frame
during the procedure
3

Techinical aspect of ERCP via LAMS

Evaluation of devices and potential pitfalls performing ERCP via LAMS

Time frame
during procedure
4

Requirement for reinterventions

Time frame
during the procedure

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.